Key role of topoisomerase I inhibitors in the treatment of recurrent and refractory epithelial ovarian carcinoma

Stephanie L. Wethington, Jason D. Wright, Thomas J. Herzog

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Key role of topoisomerase I inhibitors in the treatment of recurrent and refractory epithelial ovarian carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences